Novartis traded at $84.77 this Wednesday June 29th, increasing $0.60 or 0.71 percent since the previous trading session. Looking back, over the last four weeks, Novartis gained 6.78 percent. Over the last 12 months, its price fell by 7.09 percent. Looking ahead, we forecast Novartis to be priced at 82.65 by the end of this quarter and at 76.44 in one year, according to Trading Economics global macro models projections and analysts expectations.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 154.14 1.65 1.08% 36.84%
Amgen 245.43 1.92 0.79% 0.69%
AstraZeneca 11,054.00 268.00 2.48% 27.31%
Astrazeneca 67.02 1.09 1.65% 11.89%
Biogen 205.23 2.72 1.34% -40.73%
Bristol-Myers Squibb 78.28 -0.42 -0.53% 17.15%
Corcept Therapeutics 24.74 0.36 1.48% 12.45%
Catalent 106.15 -0.99 -0.92% -1.82%
Endo International 0.52 -0.19 -26.39% -88.83%
Gilead Sciences 62.48 0.27 0.43% -9.27%
GlaxoSmithKline 1,793.00 27.00 1.53% 26.32%
Glaxosmithkline 43.77 0.42 0.97% 9.92%
Horizon Pharma 82.50 0.81 0.99% -11.90%
Jazz Pharmaceuticals 156.36 1.12 0.72% -11.98%
J&J 176.99 0.05 0.03% 7.44%
Lannett 0.59 0 0% -87.37%
Eli Lilly 323.00 5.38 1.69% 40.73%
Merck & Co 92.51 0.62 0.67% 18.95%
Phibro Animal Health 19.19 0.03 0.16% -33.55%
Prestige Brands 56.94 -0.06 -0.11% 9.29%
Pacira 58.63 1.31 2.29% -3.38%
Pfizer 50.94 0.28 0.55% 30.08%
Powershares High Yield Orate Bond Portfolio 16.84 -0.02 -0.12% -13.82%
Perrigo 40.97 -0.08 -0.19% -10.64%
Drreddys Laboratories 55.34 0.05 0.09% -24.72%
Roche Holding 319.65 2.10 0.66% -8.29%
Sanofi 100.88 1.51 1.52% 14.17%
Sanofi 52.67 0.53 1.02% 0.02%
Supernus Pharmaceuticals 28.50 0.12 0.42% -7.44%
Teva Pharmaceutical Industries 7.95 0.12 1.53% -19.70%
United States Oil Fund 82.95 -1.77 -2.09% 66.30%
Bausch Health Companies Inc 10.98 -0.40 -3.51% -69.82%
Canopy Growth Corp 4.49 -0.15 -3.23% -85.02%
Zoetis 173.92 3.80 2.23% -6.68%


Novartis
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. The Company uses science and digital technologies for treatments in the disease areas of immunology, dermatology, cancer, ophthalmology, neuroscience, respiratory, cardiovascular, renal and metabolism. The business activities of the Company are divided into two segments: Innovative Medicines, which includes innovative patent-protected prescription medicines for blood pressure, cancer and other ailments, and Sandoz, which includes generic pharmaceuticals and biosimilars.